Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GCS-100 Extension Study in CKD
NCT02155673Phase 2Completed
- Sponsor
- La Jolla Pharmaceutical Company
- Start
- Jan 2014
- Primary completion
- May 2016
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of GCS-100 in chronic kidney disease (CKD), sponsored by La Jolla Pharmaceutical Company. Started Jan 2014; status: completed.
02
Drugs
GCS-100
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02155673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02155673.